Bank of America
FTH

Bank of America’s Faeth Therapeutics FTH Stock Holding History

Bank of America’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,025
Closed -$1.04M – 5821
2026
Q1 		$1.04M Buy
33,025
+32,719
+10,692% +$654K ﹤0.01% 4506
2025
Q4 		$3.27K Sell
306
-325
-52% -$3.14K ﹤0.01% 6337
2025
Q3 		$5.96K Buy
631
+48
+8% +$398 ﹤0.01% 7284
2025
Q2 		$5K Buy
583
+576
+8,229% +$4.13K ﹤0.01% 7295
2025
Q1 		$56 Hold
7
– – ﹤0.01% 7956
2024
Q4 		$67 Sell
7
-6
-46% -$60 ﹤0.01% 7816
2024
Q3 		$154 Buy
13
+6
+86% +$73 ﹤0.01% 7626
2024
Q2 		$86 Sell
7
-4,531
-100% -$94.3K ﹤0.01% 7736
2024
Q1 		$95.3K Sell
4,538
-1
-0% -$17 ﹤0.01% 6262
2023
Q4 		$62.8K Hold
4,539
– – ﹤0.01% 6540
2023
Q3 		$72.6K Hold
4,539
– – ﹤0.01% 6377
2023
Q2 		$103K Buy
4,539
+40
+0.9% +$1.17K ﹤0.01% 6187
2023
Q1 		$135K Buy
4,499
+2,065
+85% +$61.2K ﹤0.01% 6126
2022
Q4 		$72.5K Buy
2,434
+589
+32% +$17.3K ﹤0.01% 6357
2022
Q3 		$57K Buy
1,845
+1,001
+119% +$39.3K ﹤0.01% 6616
2022
Q2 		$38K Sell
844
-1,556
-65% -$58.3K ﹤0.01% 6962
2022
Q1 		$110K Buy
2,400
+1,148
+92% +$91.4K ﹤0.01% 6811
2021
Q4 		$146K Buy
1,252
+826
+194% +$123K ﹤0.01% 6676
2021
Q3 		$90K Sell
426
-158
-27% -$28.8K ﹤0.01% 6778
2021
Q2 		$115K Sell
584
-114
-16% -$28.2K ﹤0.01% 6441
2021
Q1 		$202K Buy
+698
New +$234K ﹤0.01% 6033

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Bank of America's FTH Position: Q2 2026 in Review

Bank of America sold out of Faeth Therapeutics (FTH) in Q2 2026, closing a stake of 33,025 shares — an estimated $1.04M sold.

Bank of America first reported a position in FTH in Q1 2021 and held it in 21 quarters. The position peaked at $1.04M in Q1 2026. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Bank of America reported no remaining Faeth Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Bank of America sold 33,025 Faeth Therapeutics shares in Q2 2026, an estimated $1.04M.
  • Bank of America first reported a position in Faeth Therapeutics in Q1 2021 and held it in 21 quarters.
  • Bank of America's Faeth Therapeutics position peaked at $1.04M in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.